Publications | Lund University Publications

1 – 5 of 5

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=keywords+exact+%22DPP-4%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2019
Mark DPP-4 inhibition and the path to clinical proof
Ahrén, Bo ^LU (2019) In Frontiers in Endocrinology 10(JUN).
- Contribution to journal › Article
2018
Mark DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes
Bugliani, Marco ; Syed, Farooq ; Paula, Flavia M.M. ; Omar, Bilal A. ^LU ; Suleiman, Mara ; Mossuto, Sandra ; Grano, Francesca ; Cardarelli, Francesco ; Boggi, Ugo and Vistoli, Fabio , et al. (2018) In Molecular and Cellular Endocrinology 473. p.186-193
- Contribution to journal › Article
2013
Mark Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function
Alba, M. ; Ahrén, Bo ^LU ; Inzucchi, S. E. ; Guan, Y. ; Mallick, M. ; Xu, L. ; O'Neill, E. A. ; Williams-Herman, D. E. ; Kaufman, K. D. and Goldstein, B. J. (2013) In Diabetes, Obesity and Metabolism 15(12). p.1101-1110
- Contribution to journal › Article
2006
Mark Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties.
Ahrén, Bo ^LU (2006) In Expert Opinion on Investigational Drugs 15(4). p.431-442
- Contribution to journal › Article
2005
Mark Alpha cell function in health and disease: influence of glucagon-like peptide-1
Dunning, B E ; Foley, J E and Ahrén, Bo ^LU (2005) In Diabetologia 48(9). p.1700-1713
- Contribution to journal › Scientific review